Skip to main content
. 2019 Oct 11;9(4):665–679. doi: 10.3233/JPD-181518

Table 2.

Summary statistics for change in the values of the outcome measures from baseline to year-5 of follow-up. NC, not collected

Outcome BL* Change* from BL to Year 1** Change* from BL to Year 2** Change* from BL to Year 3** Change* from BL to Year 4** Change* from BL to Year 5**
MDS-UPDRS Total Score Off 32.2 (13.1; 7–70; 1) 7.5 (11.6; –31–60; 79) 10.4 (12.9; –30–60; 131) 14.3 (15.6; –35–78; 158) 19.1(16.5; –20–84; 164) 20.9 (17.7; –11–111; 250)
MDS-UPDRS Total Score On 32.2 (13.1; 7–70; 1) 5.4 (12.7; –38–60; 32) 7.0 (13.4; –33–60; 59) 9.8 (16.6; 40–79; 71) 11.9 (18.0;–35–103; 92) 15.2 (19.4; 24–111; 208)
MDS-UPDRS III Score Off 20.9 (8.9; 4–51; 0) 4.5 (8.2; –22–34; 79) 6.3 (9.3; –28–45; 130) 8.8 (10.9; –28–54; 158) 11.6 (11.3;–20–54; 164) 12.3 (11.8; 3–64; 250)
MDS-UPDRS III Score On 20.6 (8.9; 4–51; 0) 2.5 (9.1; –25–34; 31) 2.6 (10.1; –31–45; 58) 3.7 (11.8; –31–39; 70) 4.1 (12.6; –27–48; 91) 5.6 (12.3; –27–58; 208)
Putamen SBR 0.82 (0.3; 0.2–2.2; 3) –13.4 (21.8; –83.1–141.2; 45) –19.2 (21.5; –86.7–167.7; 67) NC –30.9 (21.0; –83.3–123.2; 132) NC
Striatum SBR 1.4 (0.4; 0.3–2.6; 3) –11.2 (15.1;–59.6–124.8; 45) –17.1 (16.6; –87.5–146.2; 67) NC –27.7 (16.8; –83.0–104.3; 132) NC

*% Change from baseline shown for mean putamen SBR and mean striatum SBR. **Values shown are mean (SD; range (min–max); number missing) for all continuous variables.